Verition Fund Management’s Evommune EVMN Stock Holding History
Bought
Maintained
Sold
Other funds holding EVMN
BBA
KCM
Verition Fund Management's EVMN Position: Q3 2026 in Review
Verition Fund Management sold out of Evommune (EVMN) in Q3 2026, closing a stake of 43,936 shares — an estimated $584K sold.
Verition Fund Management first reported a position in EVMN in Q4 2025 and held it in 3 quarters. The position peaked at $12.6M in Q1 2026. 104 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.
- Verition Fund Management reported no remaining Evommune position as of Q3 2026 after selling out during the quarter.
- Verition Fund Management sold 43,936 Evommune shares in Q3 2026, an estimated $584K.
- Verition Fund Management first reported a position in Evommune in Q4 2025 and held it in 3 quarters.
- Verition Fund Management's Evommune position peaked at $12.6M in Q1 2026.
- 104 funds tracked by Wall St. Rank held Evommune as of Q3 2026.
Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.